Answers are grounded in this paper and cite their sources.
Nucleic acid amplification (NAA) assays for the diagnosis of Chlamydia trachomatis infections started to appear in the peer reviewed literature about 12 years ago and during that period we have seen an incredible effort put into the development and evaluation of commercially developed NAA kits to diagnose and treat infections.
No takes yet. Share an insight, caveat, or question.
Max Chernesky (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: